Credit: Tom Sofield/LevittownNow.com
A new potential treatment for lung cancer is being tested at St. Mary’s Medical Center in Middletown.
The hospital is accepting newly diagnosed patients who have not yet tried systemic medicines such as chemotherapy for a trial treatment.
Advertisements
According to a press release supplied by the hospital, the institution is now accepting eligible patients for the limited trial. The trial is occurring at limited medical institutions throughout the country.
“Nivolumab, marketed as Opdivo, is currently being advertised nationally as a breakthrough treatment for people with lung cancer. Opdivo is approved by the FDA for those with advanced lung cancer for whom chemotherapy may no longer be effective,”the statement said.
The trial is being sponsored by Bristol Myers Squibb Company, who makes Nivolumab.
Advertisements
Nivolumab has previously shown success in suppressing cancer growth. Nivolumab works with the patient’s immune system and is a targeted therapy, the release states.
If approved for the trial, patients will be assigned to different groups to test the treatment.
